CRISPR Reveals New Targets for Promising Cancer Drugs

News   Jul 20, 2017 | Original story from Harvard University

 
CRISPR Reveals New Targets for Promising  Cancer Drugs

redit: Haining Lab, Dana-Farber/Boston Children’s Genetic screening for cancer immunotherapy targets cancer cells (colored shapes), each with a different CRISPR-Cas9-mediated gene knocked out. T cells (red) destroy the cancer cells that have had essential immune evasion genes knocked out.

 
 
 

RELATED ARTICLES

Concept Life Sciences and Alderley Analytical Partner to provide Bioanalytical and DMPK Services

News

Companies announced they have signed a partnership agreement to provide high-value bioanalytical and DMPK study services.

READ MORE

CRISPR Technology Used to Make Stem Cells

News

In a world first, CRISPR genome editing has been used to reprogram skin cells to function as pluripotent stem cells.

READ MORE

Magnetic MicroRNAs Could Help Treat Incontinence

News

An unlikely combination of magnets and MicroRNAs might be a novel treatment for constipation and incontinence patients.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Cell Science Drug Discovery Informatics & Automation

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE